Gupta N, Ahmed I, Nissel-Horowitz S, Patel D, Mehrotra B
Long Island Jewish Medical Center, Department of Medicine, New Hyde Park, New York 11042, USA.
Am J Hematol. 2001 Feb;66(2):151-2. doi: 10.1002/1096-8652(200102)66:2<151::AID-AJH1035>3.0.CO;2-Q.
Intravenous gammaglobulins are used for the treatment of various auto-immune hematological disorders. Renal failure is a relatively rare, but an increasingly recognized side effect of gammaglobulin therapy. Although the renal failure is usually reversible, renal replacement therapy is required occasionally. A high index of suspicion, early recognition and appropriate intervention can prevent this complication. We herewith describe two patients with an immune hematological disorder, who developed acute renal failure after treatment with intravenous gammaglobulins. A brief review of the possible risk factors, pathophysiology and management of this complication is provided.
静脉注射免疫球蛋白用于治疗各种自身免疫性血液疾病。肾衰竭是免疫球蛋白治疗相对罕见但日益被认识到的副作用。虽然肾衰竭通常是可逆的,但偶尔需要进行肾脏替代治疗。高度怀疑、早期识别和适当干预可预防这一并发症。我们在此描述两名患有免疫性血液疾病的患者,他们在接受静脉注射免疫球蛋白治疗后发生了急性肾衰竭。并对该并发症可能的危险因素、病理生理学和管理进行简要综述。